Administration of serelaxin to patients admitted for AHF was associated with a highly significant reduction in the risk of 5-day worsening HF and in changes in renal function markers.
← all excerpts
Searching for Preclinical Models of Acute Decompensated Heart Failure: a Concise Narrative Overview and a Novel Swine Model.
1
—
—